Toronto, Ontario–(Newsfile Corp. – December 21, 2020) – Relay Medical Corp. (CSE: RELA) (OTC: RYMDF) (FSE: EIY2) (“Relay” or the “Company“) is pleased to announce the appointment of Derek Ivany to the Company’s Advisory Board. Mr. Ivany will advise Relay on corporate development, mergers, acquisitions, and other strategic initiatives.

“Derek brings a wealth of experience and skill to Relay that is absolutely crucial at the Company’s current stage of development, and commercial activity,” said Yoav Raiter, CEO, Relay Medical Corp. “We are excited to welcome Derek to the Relay team and look forward to working with him to maximize our potential.”

Mr. Ivany was most recently the President and CEO of a publicly traded company that, during his tenure, expanded in valuation from $2M in market capitalization to over $250M at its zenith while generating significant investor liquidity along the way. Over the last year he has raised an additional $10M in both the biotech space where he launched a publicly traded company Pilz BioScience focused on Autism Spectrum Disorder research and is a strategic capital advisor and CEO of Holy Crap Brands where he recently advised VEGN.

“Relay is on the tip of the spear of today’s unprecedented healthcare struggles and I am very pleased to work with the team to help global communities and economies, handle current struggles and prepare for the future in a post-COVID world,” said Derek Ivany, Strategic Advisor.

Mr. Ivany has a rich history of successfully working with publicly traded companies and helping generate significant shareholder value in a variety of diverse industry segments. Having worked with many international groups, Mr. Ivany has established a network of high-profile contacts across such sectors as medicinal products, health and wellness, mining, oil and gas, coffee, technology, horse racing & real-estate. Derek is currently the President of JJ Wolf Investments Ltd., a merchant banking and advisory firm specializing in growth oriented opportunities across all sectors as well as the President of several private companies around the world. Derek also serves as a Senior Advisor to MidPoint Technology Holdings.

SUBSCRIBE: For more information on Relay or to subscribe to the Company’s mail list visit: https://www.relaymedical.com/news

About Relay Medical Corp.

Relay Medical is a MedTech innovation Company headquartered in Toronto, Canada focused on the development of novel technologies in the diagnostics and AI data science sectors.

Website: www.relaymedical.com

Contact:
W. Clark Kent
President
Relay Medical Corp.
Office. 647-872-9982 ext. 2
TF. 1-844-247-6633 ext. 2
[email protected]

Bernhard Langer
EU Investor Relations
Office. +49 (0) 177 774 2314
Email: [email protected]

Forward-looking Information Cautionary Statement

Except for statements of historic fact, this news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. There are uncertainties inherent in forward-looking information, including factors beyond the Company’s control. There are no assurances that the commercialization plans for the technology described in this news release will come into effect on the terms or time frame described herein. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. The reader is cautioned not to place undue reliance on forward-looking statements. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which filings are available at www.sedar.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/70721